OAM
Oberweis Asset Management’s Haemonetics HAE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-224,920
| Closed | -$17.6M | – | 199 |
|
|
2024
Q4 | $17.6M | Buy |
224,920
+47,125
| +27% | +$3.68M | 0.83% | 38 |
|
|
2024
Q3 | $14.3M | Buy |
177,795
+12,500
| +8% | +$1M | 0.73% | 42 |
|
|
2024
Q2 | $13.7M | Buy |
165,295
+21,600
| +15% | +$1.79M | 0.84% | 39 |
|
|
2024
Q1 | $12.3M | Buy |
143,695
+37,815
| +36% | +$3.23M | 0.89% | 29 |
|
|
2023
Q4 | $9.05M | Buy |
105,880
+28,480
| +37% | +$2.44M | 0.84% | 21 |
|
|
2023
Q3 | $6.93M | Buy |
77,400
+29,900
| +63% | +$2.68M | 0.74% | 31 |
|
|
2023
Q2 | $4.04M | Buy |
47,500
+10,600
| +29% | +$902K | 0.49% | 75 |
|
|
2023
Q1 | $3.05M | Buy |
36,900
+17,200
| +87% | +$1.42M | 0.47% | 65 |
|
|
2022
Q4 | $1.55M | Buy |
+19,700
| New | +$1.55M | 0.33% | 107 |
|
|
2019
Q1 | – | Sell |
-40,535
| Closed | -$4.06M | – | 209 |
|
|
2018
Q4 | $4.06M | Sell |
40,535
-12,365
| -23% | -$1.24M | 0.91% | 30 |
|
|
2018
Q3 | $6.06M | Buy |
52,900
+18,480
| +54% | +$2.12M | 1.17% | 26 |
|
|
2018
Q2 | $3.09M | Buy |
+34,420
| New | +$3.09M | 0.78% | 38 |
|